Publication | Open Access
Cardiac Late Sodium Channel Current Is a Molecular Target for the Sodium/Glucose Cotransporter 2 Inhibitor Empagliflozin
191
Citations
47
References
2021
Year
Our results provide evidence that late-<i>I</i><sub>Na</sub> may be an important molecular target in the heart for the SGLT2 inhibitors, contributing to their unexpected cardioprotective effects.
| Year | Citations | |
|---|---|---|
Page 1
Page 1